AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Heartflow, Inc. (HTFL)
Company Research
Source: GlobeNewswire
NEW ORLEANS, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced late-breaking data from the FISH&CHIPS Study presented at the American Heart Association (AHA) Scientific Sessions 2025. The new data add to the robust and growing body of evidence supporting AI-powered Heartflow Plaque Analysis with Heartflow Plaque Staging* — the most clinically validated framework for actionable CAD care. The retrospective analysis, which evaluated nearly 8,000 symptomatic patients from a cohort of the FISH&CHIPS Study, represents the largest validation to date of the Heartflow Plaque Staging framework based on total plaque volume (TPV) measurement.1 Key findings include: Patients in the highest TPV stage experienced more than a 5x greater risk of major cardiovascular events compared with patients in the lowest stage (hazard ratio 5.10, p-value Higher plaque volume stages were independently as
Show less
Read more
Impact Snapshot
Event Time:
HTFL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HTFL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HTFL alerts
High impacting Heartflow, Inc. news events
Weekly update
A roundup of the hottest topics
HTFL
News
- Heartflow to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $39.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- Heartflow (NASDAQ:HTFL) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
- Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- Heartflow Reports Third Quarter 2025 Financial ResultsGlobeNewswire
HTFL
Earnings
- 11/12/25 - In-Line
HTFL
Sec Filings
- 11/12/25 - Form 4
- 11/12/25 - Form 4
- 11/12/25 - Form 4
- HTFL's page on the SEC website